July 27, 2018
bluebird bio
bluebird bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 25, 2018
Blueprint Medicines
Blueprint Medicines to Report Second Quarter 2018 Financial Results on Wednesday, August 1, 2018
July 24, 2018
Sage Therapeutics
Sage Therapeutics to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018
July 24, 2018
bluebird bio
bluebird bio’s LentiGlobin™ Gene Therapy Granted Accelerated Assessment by European Medicines Agency for the Treatment of Transfusion-Dependent β-Thalassemia
July 23, 2018
bluebird bio
bluebird bio Announces Proposed Public Offering of Common Stock